Genomic BRCA and Extensive ovArian Cancer Testing

Inclusion Criteria

• •Patient older than 18 years.
• •Patient with ovarian and/or primitive peritoneal and/or fallopian tubes carcinoma, histologically confirmed, with an advanced stage at diagnosis (stage III to IV FIGO 2014)
• •Patient in first line therapy
• •Available tumor sample fixed in formalin and included in paraffin (FFPE):
• •* in pre-chemotherapy, insofar as possible
• •* having a sufficient tumor surface, with a final cellularity of at least 20%
• •Identification of a molecular genetics' cancer platform participant in GREAT and an onco-geneticists team working with the investigator team
• •Patient consenting her data to be collected and submitted through an automated processing
• •Patient beneficiary from the French social security